Phase 1, placebo-controlled, single ascending dose trial to evaluate the safety, pharmacokinetics and effect on altered states of consciousness of intranasal BPL-003 (5-methoxy-N,N-dimethyltryptamine benzoate) in healthy participants

James Jonathan Rucker, Claire Roberts*, Mathieu Seynaeve, Allan H. Young, Ben Suttle, Takahiro Yamamoto, Anna O. Ermakova, Fiona Dunbar, Frank Wiegand

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Phase 1, placebo-controlled, single ascending dose trial to evaluate the safety, pharmacokinetics and effect on altered states of consciousness of intranasal BPL-003 (5-methoxy-N,N-dimethyltryptamine benzoate) in healthy participants'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science